BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18797063)

  • 41. Safety and Efficacy of Methotrexate in Psoriasis: A Meta-Analysis of Published Trials.
    West J; Ogston S; Foerster J
    PLoS One; 2016; 11(5):e0153740. PubMed ID: 27168193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Methotrexate in psoriasis: do we need to give a test dose?].
    Carretero-Hernández G
    Actas Dermosifiliogr; 2012; 103(1):1-4. PubMed ID: 22093543
    [No Abstract]   [Full Text] [Related]  

  • 43. A retrospective review of methotrexate-induced hepatotoxicity among patients with psoriasis in a tertiary dermatology center in Malaysia.
    Ng LC; Lee YY; Lee CK; Wong SM
    Int J Dermatol; 2013 Jan; 52(1):102-5. PubMed ID: 23278617
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low dose methotrexate induced asymptomatic keratinocyte dystrophy in a patient of psoriasis vulgaris.
    Behera B; Kumari R; Gochhait D; Thappa DM
    J Cutan Pathol; 2016 Dec; 43(12):1238-1241. PubMed ID: 27714834
    [No Abstract]   [Full Text] [Related]  

  • 45. Methotrexate revisited: effects of long-term treatment in psoriasis.
    Van Dooren-Greebe RJ; Kuijpers AL; Mulder J; De Boo T; Van de Kerkhof PC
    Br J Dermatol; 1994 Feb; 130(2):204-10. PubMed ID: 8123573
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Methotrexate in psoriasis: are routine biopsies necessary?].
    Guillaume JC
    Ann Dermatol Venereol; 2006; 133(6-7):513-7. PubMed ID: 16885837
    [No Abstract]   [Full Text] [Related]  

  • 47. Diffuse Large B-Cell Lymphoma of the Gingiva in a Patient on Long-Term Use of Methotrexate Being Treated for Psoriasis.
    Shapiro N
    Compend Contin Educ Dent; 2015 Jun; 36(6):426-8. PubMed ID: 26053781
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemic methotrexate treatment in childhood psoriasis: further experience in 24 children from India.
    Kaur I; Dogra S; De D; Kanwar AJ
    Pediatr Dermatol; 2008; 25(2):184-8. PubMed ID: 18429775
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biomarkers for methotrexate-induced liver injury: urinary protein profiling of psoriasis patients.
    van Swelm RP; Laarakkers CM; Kooijmans-Otero M; de Jong EM; Masereeuw R; Russel FG
    Toxicol Lett; 2013 Aug; 221(3):219-24. PubMed ID: 23830989
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-Hodgkin's lymphoma in patients with rheumatoid arthritis treated with low dose methotrexate.
    Usman AR; Yunus MB
    J Rheumatol; 1996 Jun; 23(6):1095-7. PubMed ID: 8782146
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Toxicity of methotrexate treatment in psoriasis and psoriatic arthritis--short- and long-term toxicity in 104 patients.
    Wollina U; Ständer K; Barta U
    Clin Rheumatol; 2001; 20(6):406-10. PubMed ID: 11771523
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methotrexate in childhood psoriasis.
    Kumar B; Dhar S; Handa S; Kaur I
    Pediatr Dermatol; 1994 Sep; 11(3):271-3. PubMed ID: 7971565
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cerebral non-Hodgkin's lymphoma discovered when treating Hodgkin's disease.
    Bergeron C; Le Moine P; Le Prise-Fleury E; Jouan H; Tass P; Darcel F; Chatel M; Edan C; Patte C; Faivre J
    Med Pediatr Oncol; 1993; 21(4):307-10. PubMed ID: 8469228
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hodgkin's disease and B cell lymphoproliferation in rheumatoid arthritis patients treated with methotrexate: a kinetic study of lymph node changes.
    Chevrel G; Berger F; Miossec P; Blanc M; Jeanneret J; Felman C; Tebib J
    Arthritis Rheum; 1999 Aug; 42(8):1773-6. PubMed ID: 10446880
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A pilot study of cyclical chemotherapy with high-dose methotrexate and CHOP (MTX-CHOP) in poor-prognosis non-Hodgkin's lymphoma (NHL).
    Child JA; Barnard DL; Cartwright SC; Lauder I; Simmons AV; Stone J; Thorogood J
    Cancer Chemother Pharmacol; 1983; 11(3):153-8. PubMed ID: 6688970
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of mycophenolate mofetil vs. methotrexate for the treatment of chronic plaque psoriasis.
    Akhyani M; Chams-Davatchi C; Hemami MR; Fateh S
    J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1447-51. PubMed ID: 20384673
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low-dose weekly oral methotrexate therapy for inflammatory arthritis.
    Boh LE; Schuna AA; Pitterle ME; Adams EM; Sundstrom WR
    Clin Pharm; 1986 Jun; 5(6):503-8. PubMed ID: 3720217
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bullous drug eruption in a patient with psoriasis after a test dose of methotrexate.
    Sako EY; Famenini S; Wu JJ
    J Am Acad Dermatol; 2013 Nov; 69(5):e264-e265. PubMed ID: 24124857
    [No Abstract]   [Full Text] [Related]  

  • 59. Infliximab for the treatment of psoriasis in the U.K.: 9 years' experience of infusion reactions at a single centre.
    Wee JS; Petrof G; Jackson K; Barker JN; Smith CH
    Br J Dermatol; 2012 Aug; 167(2):411-6. PubMed ID: 22404545
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methotrexate nodulosis.
    Jang KA; Choi JH; Moon KC; Yoo B; Sung KJ; Koh JK
    J Dermatol; 1999 Jul; 26(7):460-4. PubMed ID: 10458088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.